PubMed

The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.

Xu S, Jiang B, Maitland KA, Bayat H, Gu J, Nadler JL, Corda S, Lavielle G, Verbeuren TJ, Zuccollo A, Cohen RA.

Diabetes. 2006 Jan;55(1):110-9.PMID: 16380483 [PubMed - indexed for MEDLINE]Related articlesFree article

The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, Xu S, Jiang B, Oliver-Krasinski JM, Cayatte AJ, Corda S, Lavielle G, Verbeuren TJ, Cohen RA.

Circulation. 2005 Nov 8;112(19):3001-8. Epub 2005 Oct 31.PMID: 16260636 [PubMed - indexed for MEDLINE]Related articlesFree article

The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.

Cayatte AJ, Du Y, Oliver-Krasinski J, Lavielle G, Verbeuren TJ, Cohen RA.

Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1724-8.PMID: 10894809 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes.

Sebeková K, Eifert T, Klassen A, Heidland A, Amann K.

Diabetes. 2007 Apr;56(4):968-74. Epub 2007 Jan 31.PMID: 17267764 [PubMed - indexed for MEDLINE]Related articlesFree article

S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits.

Worth NF, Berry CL, Thomas AC, Campbell JH.

Atherosclerosis. 2005 Nov;183(1):65-73. Epub 2005 Jun 9.PMID: 15950232 [PubMed - indexed for MEDLINE]Related articles

Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.

Ding H, Hashem M, Triggle C.

Eur J Pharmacol. 2007 Apr 30;561(1-3):121-8. Epub 2007 Jan 20.PMID: 17292348 [PubMed - indexed for MEDLINE]Related articles

Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban).

van der Hoorn JW, Jukema JW, Bekkers ME, Princen HM, Corda S, Emeis JJ, Steendijk P.

Crit Care Med. 2008 Sep;36(9):2576-82.PMID: 18679128 [PubMed - indexed for MEDLINE]Related articles

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.PMID: 17420349 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice.

Luo JD, Wang YY, Fu WL, Wu J, Chen AF.

Circulation. 2004 Oct 19;110(16):2484-93. Epub 2004 Jul 19.PMID: 15262829 [PubMed - indexed for MEDLINE]Related articlesFree article

Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice.

Michel F, Simonet S, Vayssettes-Courchay C, Bertin F, Sansilvestri-Morel P, Bernhardt F, Paysant J, Silvestre JS, Levy BI, Félétou M, Verbeuren TJ.

Am J Physiol Renal Physiol. 2008 Jan;294(1):F120-9. Epub 2007 Oct 17.PMID: 17942572 [PubMed - indexed for MEDLINE]Related articlesFree article

A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.

Vilahur G, Casaní L, Badimon L.

Thromb Haemost. 2007 Sep;98(3):662-9.PMID: 17849057 [PubMed - indexed for MEDLINE]Related articles

The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertension.

Sebeková K, Ramuscak A, Boor P, Heidland A, Amann K.

Am J Nephrol. 2008;28(1):47-53. Epub 2007 Sep 21.PMID: 17890857 [PubMed - indexed for MEDLINE]Related articles

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.

Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Diabetologia. 2006 Apr;49(4):766-74. Epub 2006 Feb 4.PMID: 16463048 [PubMed - indexed for MEDLINE]Related articles

Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1.

Song F, Qi X, Chen W, Jia W, Yao P, Nussler AK, Sun X, Liu L.

Eur J Nutr. 2007 Mar;46(2):61-9.PMID: 17278042 [PubMed - indexed for MEDLINE]Related articles

Effects of NADPH oxidase inhibitor in diabetic nephropathy.

Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS.

Kidney Int. 2005 May;67(5):1890-8.PMID: 15840036 [PubMed - indexed for MEDLINE]Related articles

Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.

Chen YJ, Li J, Quilley J.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2305-12. Epub 2008 Mar 7.PMID: 18326808 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL.

Diabetes. 2006 Nov;55(11):3112-20.PMID: 17065350 [PubMed - indexed for MEDLINE]Related articlesFree article

Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine.

Guo Z, Xia Z, Jiang J, McNeill JH.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1728-36. Epub 2006 Nov 22.PMID: 17122189 [PubMed - indexed for MEDLINE]Related articlesFree article

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA.

Circulation. 2005 Jan 25;111(3):334-42. Epub 2005 Jan 17. Erratum in: Circulation. 2005 May 10;111(18):2412. Fries, Susanne [added]. PMID: 15655126 [PubMed - indexed for MEDLINE]Related articlesFree article

Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress.

Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, Pugliese G.

Diabetes. 2006 Jun;55(6):1642-50.PMID: 16731826 [PubMed - indexed for MEDLINE]Related articlesFree article